Lisata Therapeutics Announces New Method of Use Patent Granted for Certepetide in the Treatment of Pancreatic Cancer and Other Solid Tumors

Go back to Lisata Therapeutics Announces New Method of Use Patent Granted for Certepetide in the Treatment of Pancreatic Cancer and Other Solid Tumors
(NASDAQ: LSTA) Delayed: 1.01 -0.04 (3.81%)
Previous Close $1.05    52 Week High $ 
Open $1.06    52 Week Low $ 
Day High $1.06    P/E N/A 
Day Low $1.00    EPS $ 
Volume 27,669